Showing results (1-10 of 339) with videos related to
Sort By:
Pageof 34
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas PircherFrontiers in Cell and Developmental Biology|September 25, 2020
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future PerspectivesLaurenz Nagl, Lena Horvath, Andreas Pircher, et al.BMJ Case Reports|July 5, 2012
Durable complete remission in a patient with recurrent DLBCL receiving rituximab monotherapy after high-dose chemotherapy and autologous stem cell transplantationAndreas Pircher, Eva Maria Gassner, Michael Steurer, et al.Molecular Cancer|September 12, 2020
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlookLena Horvath, Bernard Thienpont, Liyun Zhao, et al.Frontiers in Cell and Developmental Biology|January 20, 2021
The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer - New Combinational Approaches and Strategies of Neovessel InhibitionSophia Daum, Hannes Hagen, Erin Naismith, et al.International Journal of Molecular Sciences|August 7, 2021
The Biology of Classic Hairy Cell LeukemiaJan-Paul Bohn, Stefan Salcher, Andreas Pircher, et al.Journal of Cellular Physiology|April 28, 2015
Treg(s) in Cancer: Friends or Foe?Dominik Wolf, Sieghart Sopper, Andreas Pircher, et al.Cancers|March 10, 2022
Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General PopulationJan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, et al.International Journal of Molecular Sciences|November 1, 2017
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical RealityAndreas Pircher, Dominik Wolf, Axel Heidenreich, et al.Current Opinion in Oncology|October 15, 2019
Angiogenesis inhibition in non-small cell lung cancer: a critical appraisal, basic concepts and updates from American Society for Clinical Oncology 2019Anna Rita Cantelmo, Camille Dejos, Florian Kocher, et al.Pageof 34